IRIS
NOCERA, LUIGI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 186
EU - Europa 181
AS - Asia 92
AF - Africa 4
OC - Oceania 1
SA - Sud America 1
Totale 465
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 185
SE - Svezia 109
CN - Cina 52
SG - Singapore 32
RU - Federazione Russa 22
IT - Italia 16
DE - Germania 10
FI - Finlandia 6
IN - India 6
GB - Regno Unito 5
ES - Italia 4
IE - Irlanda 4
NG - Nigeria 4
CZ - Repubblica Ceca 2
AU - Australia 1
BE - Belgio 1
BG - Bulgaria 1
CA - Canada 1
IR - Iran 1
PE - Perù 1
PL - Polonia 1
TR - Turchia 1
Totale 465
Salva come PNG Salva come JPEG
Città #
Ashburn 42
Shanghai 27
New York 22
Singapore 22
Lawrence 20
Princeton 20
Boardman 17
Moscow 8
Rome 7
Pune 6
Helsinki 5
Dublin 4
Bilbao 3
Alvin 2
Cologne 2
Croydon 2
Frankfurt am Main 2
Hanover 2
Holyhead 2
Lagos 2
Mushin 2
Quanzhou 2
Shenzhen 2
Soverato Marina 2
Xi'an 2
Beijing 1
Borås 1
Brussels 1
Calgary 1
Crotone 1
Fort Lauderdale 1
Fuzhou 1
Guangzhou 1
Haining 1
Kish 1
Lappeenranta 1
Los Angeles 1
Majadahonda 1
Melbourne 1
Middlesbrough 1
Padova 1
San Antonio 1
San Mateo 1
Santa Clara 1
The Bronx 1
Tucson 1
Washington 1
Zhuji 1
Totale 250
Salva come PNG Salva come JPEG
Nome #
Androgen annihilation versus advanced androgen blockage as first line treatment for metastatic castration resistant prostate cancer: A systematic review and meta-analysis 34
Chemotherapy and advanced androgen blockage, alone or combined, for metastatic hormone-sensitive prostate cancer a systematic review and meta-analysis 31
A Nomogram-Based Model to Predict Respiratory Dysfunction at 6 Months in Non-Critical COVID-19 Survivors 28
Immunotherapy versus chemotherapy as first-line treatment for advanced urothelial cancer: A systematic review and meta-analysis 25
Immunotherapy in advanced kidney cancer: an alternative meta-analytic method using reconstructed survival data in case of proportional hazard assumption violation 24
Efficacy and toxicity of antibody-drug conjugates in the treatment of metastatic urothelial cancer: A scoping review 23
Pembrolizumab in advanced renal cell carcinoma: a meta-analysis providing level 1a evidence 22
Predicting the risk of pT3a stage in cT1 clear cell renal cell carcinoma 21
Improving the stratification of intermediate risk prostate cancer 21
Surgical Safety of Radical Cystectomy and Pelvic Lymph Node Dissection Following Neoadjuvant Pembrolizumab in Patients with Bladder Cancer: Prospective Assessment of Perioperative Outcomes from the PURE-01 Trial 20
Impact of Early Dorsal Venous Complex Ligation on Urinary Continence Recovery after Robot-assisted Radical Prostatectomy: Results from a Phase 3 Randomized Controlled Trial 19
Incidence and Survival Rates of Contemporary Patients with Invasive Upper Tract Urothelial Carcinoma 19
External beam radiation therapy improves survival in low-volume metastatic prostate cancer patients: a North American population-based study 17
Comparison of Mexican-American vs Caucasian prostate cancer active surveillance candidates 17
Race/Ethnicity Determines Life Expectancy in Surgically Treated T1aN0M0 Renal Cell Carcinoma Patients 17
Sex-Related Differences Include Stage, Histology, and Survival in Urethral Cancer Patients 16
Comparison between 1973 and 2004/2016 WHO grading systems in patients with Ta urothelial carcinoma of urinary bladder 15
Use of 18F-fluoro-2-deoxy-d-glucose (18F-FDG) PET/CT for lymph node assessment before radical cystectomy in bladder cancer patients 14
The effect of race/ethnicity on histological subtype distribution, stage at presentation and cancer specific survival in urethral cancer 14
Differences between rural and urban prostate cancer patients 13
Re: Hiten D. Patel, Farzana A. Faisal, Bruce J. Trock, et al. Effect of Pharmacologic Prophylaxis on Venous Thromboembolism After Radical Prostatectomy: The PREVENTER Randomized Clinical Trial. Eur Urol 2020;78:360–368 13
Comparison Between Urothelial and Non-Urothelial Urethral Cancer 13
The effect of race/ethnicity on active treatment rates among septuagenarian or older low risk prostate cancer patients 13
Tumor Stage and Substage Predict Cancer-specific Mortality After Nephrectomy for Nonmetastatic Renal Cancer: Histological Subtype-specific Validation 12
The impact of race/ethnicity on upstaging and/or upgrading rates among intermediate risk prostate cancer patients treated with radical prostatectomy 12
Neoadjuvant pembrolizumab and radical cystectomy in patients with muscle-invasive urothelial bladder cancer: 3-year median follow-up update of PURE-01 trial 11
The effect of lymph node dissection on cancer-specific survival in salvage radical prostatectomy patients 7
ASSOCIATION BETWEEN POLYMORPHISMS OF HOMOLOGOUS RECOMBINATION RAD51B AND DISEASE RECURRENCE IN A PROSPECTIVE COHORT OF PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY 2
Totale 493
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.781
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.781
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202115 0 0 0 0 0 9 0 0 6 0 0 0
2021/202222 0 2 1 12 0 0 1 0 2 1 0 3
2022/2023177 50 39 18 8 7 23 5 16 6 1 3 1
2023/2024183 3 12 14 20 17 38 1 39 0 6 8 25
2024/202596 50 17 13 9 7 0 0 0 0 0 0 0
Totale 493